Explore: Biotech · Generative AI · Drug Discovery · Climate Tech · Pre-Seed · Seed · Series A
AlleyCorp Fund II
AlleyCorp
vc$250MCo-investsLeads rounds
Investment Thesis
Early-stage bets on companies where it's not yet obvious, with focus on first checks under $10 million. Kevin Ryan invests based on where the world is going five to ten years from now.
About AlleyCorp Fund II
$250 million institutional VC fund (Fund I) raised in 2024 with external LPs for the first time, transitioning from a family office to an institutional firm.
Sectors
BiotechGenerative AIDrug DiscoveryClimate Tech
Stages
pre-seedseedSeries ASeries B
Geographic focus
United States
Team
| Kevin Ryan |
Full team enrichment — titles, roles, LinkedIn, X and email where availableSign in to view
Notable Investments
MongoDB, Reddit, Meetup, Spring Health, Blueground, Thyme Care, Pearl Health, Portal Space Systems, Vanna Health
Verified 15 July 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does AlleyCorp Fund II invest in?
- AlleyCorp Fund II invests in Biotech, Generative AI, Drug Discovery and Climate Tech at the pre-seed, seed, series-a and series-b stages.
- Which geographies does AlleyCorp Fund II focus on?
- AlleyCorp Fund II focuses on United States, and is headquartered in United States.